55 results
Page 2 of 3
8-K
EX-10.4
hxt9j8agdh
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.3
8gwmam
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.2
ww99lj17znp
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
DEFM14A
h9tzloa6twi8 iv
6 Nov 18
Proxy related to merger
12:00am
424B3
bomc0f yn4f
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
1thflr6yhrnd2kgwx8f
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
tq6vg2yydvuyme5s
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
eaijmw0cryokyal72
9 Aug 18
Business combination disclosure
5:17pm